Month: June 2019

Pablo Lamelas – In the recent years several randomized trials comparing complete vs culprit-only revascularization were published, in which many of them were ¨positive¨. Then, do we have a definitive … Continue reading Complete vs culprit-only revascularization in STEMI

Pablo Lamelas – In 2016 two large randomized trials testing the role of PCI in left main (LM) disease were published, which seem inconsistent. Are they? what the body of … Continue reading PCI vs CABG for left main disease: EXCEL Vs NOBLE

Pablo Lamelas – AUGUSTUS was the last (until mid 2019) large randomized controlled trial evaluating antithrombotic therapy in patients with atrial fibrillation with indication of oral alticoagulation and concomitant indication … Continue reading Atrial fibrillation and PCI after AUGUSTUS

Pablo Lamelas – At ACC 2019 meeting two large randomized trials of patients at low-risk of Surgical Aortic Valve Replacement (SAVR): PARTNER 3 and EVOLUT low-risk. Here we summarize the … Continue reading TAVR in low-risk patients